Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
about
Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly.Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma.Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo.Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.
P2860
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
@en
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
@nl
type
label
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
@en
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
@nl
prefLabel
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
@en
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
@nl
P2093
P356
P1433
P1476
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
@en
P2093
A M Levine
B M Espina
B Nathwani
D McDonald
G R Justice
J Bernstein
P304
P356
10.1023/A:1011181016401
P577
2001-04-01T00:00:00Z